ANL 31.05 Decreased By ▼ -0.76 (-2.39%)
ASC 19.01 Decreased By ▼ -0.18 (-0.94%)
ASL 27.35 Decreased By ▼ -0.75 (-2.67%)
AVN 91.39 Increased By ▲ 0.69 (0.76%)
BOP 8.38 Decreased By ▼ -0.12 (-1.41%)
BYCO 13.03 Increased By ▲ 0.20 (1.56%)
DGKC 130.75 Increased By ▲ 2.15 (1.67%)
EPCL 49.44 Increased By ▲ 1.64 (3.43%)
FCCL 24.40 Increased By ▲ 0.03 (0.12%)
FFBL 26.95 Increased By ▲ 0.35 (1.32%)
FFL 17.49 Decreased By ▼ -0.36 (-2.02%)
HASCOL 11.90 Increased By ▲ 0.15 (1.28%)
HUBC 81.00 Increased By ▲ 2.49 (3.17%)
HUMNL 8.49 Decreased By ▼ -0.19 (-2.19%)
JSCL 24.30 Decreased By ▼ -0.30 (-1.22%)
KAPCO 43.63 Decreased By ▼ -0.38 (-0.86%)
KEL 4.70 Increased By ▲ 0.48 (11.37%)
LOTCHEM 16.20 Increased By ▲ 0.35 (2.21%)
MLCF 49.32 Increased By ▲ 0.42 (0.86%)
PAEL 36.20 Decreased By ▼ -0.55 (-1.5%)
PIBTL 11.39 Decreased By ▼ -0.01 (-0.09%)
POWER 10.54 Decreased By ▼ -0.05 (-0.47%)
PPL 92.40 Decreased By ▼ -2.10 (-2.22%)
PRL 26.70 Decreased By ▼ -0.69 (-2.52%)
PTC 12.90 Decreased By ▼ -0.52 (-3.87%)
SILK 1.61 Decreased By ▼ -0.01 (-0.62%)
SNGP 49.35 Decreased By ▼ -1.13 (-2.24%)
TRG 165.90 Increased By ▲ 3.40 (2.09%)
UNITY 48.30 Decreased By ▼ -0.15 (-0.31%)
WTL 3.99 Decreased By ▼ -0.24 (-5.67%)
BR100 5,333 Increased By ▲ 1.35 (0.03%)
BR30 27,937 Increased By ▲ 164.91 (0.59%)
KSE100 48,633 Decreased By ▼ -93.52 (-0.19%)
KSE30 19,625 Decreased By ▼ -22.41 (-0.11%)

WHO approves China’s Sinopharm vaccine for emergency use

  • WHO gave emergency use listing to Beijing's Sinopharm Covid-19 vaccine, making it the sixth overall, and the first Chinese vaccine to receive WHO validation for safety, efficacy, and quality.
Updated 07 May 2021

The World Health Organization (WHO) on Friday approved the Sinpoharm vaccine for emergency use against the Covid-19. With this development, Sinopharm became China’s first coronavirus vaccine to get the WHO’s nod for international use.

Addressing a press conference in this regard, the WHO’s director-general, Tedros Adhanom Ghebreyesus said:

“This afternoon, WHO gave emergency use listing to Beijing's Sinopharm Covid-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy, and quality.”

The other five emergency use vaccines to get WHO listings are made by Pfizer-BioNTech, Moderna, Johnson, and Johnson, and the AstraZeneca being produced at separate sites in India and in South Korea.

The approval means that Sinopharm will be included in Covax, the UN health agency’s global initiative that is designed to promote equitable vaccine distribution around the world.

According to an AFP, the Sinopharm vaccine being used in 42 territories around the world, is the fourth behind AstraZeneca (166), Pfizer-BioNTech (94), and Moderna (46).

Besides China, it is being used in Algeria, Cameroon, Egypt, Hungary, Iraq, Iran, Pakistan, Peru, the United Arab Emirates, Serbia, and Seychelles, among others.

It is a developing story, will be updated accordingly.